Mr. Bill Fleming reports

ABATTIS ANNOUNCES PRIVATE PLACEMENT

Abattis Bioceuticals Corp. has closed the announced private placement of up to $297,454. Under the terms of the private placement, Abattis issued up to 5,949,080 units. Each unit will consist of one common share at five cents per share and one full share purchase warrant. One warrant will be exercisable into one common share at a price of nine cents per common share. The expiry date for the exercise of the warrants will be 24 months after the closing of this unit offering.

Proceeds of this offering will be used for the production and sale of hemp water, research and development, marketing, working capital, and general corporate purposes. The shares will be subject to a Canadian resale hold period expiring four months and one day from the closing.

Further, the company is pleased to announce that, in compliance with the company's option plan, the company has granted 3.9 million incentive stock options to certain of its directors, officers and consultants, with each option being exercisable into a common share of Abattis at six cents per share for a period of five years.

We seek Safe Harbor.